Tissue Regenix appoints non-executive director Couldwell as new chief executive
"Steve has the required skill-set and experience to guide the group along the pathway to profitability," said John Samuel, chairman of Tissue Regenix
Company
LON:TRX
Tissue Regenix Group PLC is a pioneering, international medical technology company, focusing on the development of regenerative products utilising its two platform technologies, dCELL, addressing soft tissue needs, and BioRinse, providing sterile bone allografts. The company is currently helping to transform the treatment of patients in key surgical applications: biosurgery, orthopaedics (sports medicine/spine), dental, general, plastic surgery, urology/gynaecology, ophthalmology and cardiac.
255 stories · page 9 of 13
"Steve has the required skill-set and experience to guide the group along the pathway to profitability," said John Samuel, chairman of Tissue Regenix
The FTSE 100 closed out Thursday up around 67 points at 7,555.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London today
Odell had been in the role since 2008 and will be replaced temporarily by non-executive chairman, John Samuel.
FTSE 100 closed at 7,542, below last Thursday’s closing high of 7,556.24 while the Dow soared above the 23,000 level today
Strong sales in its GBM-V and DermaPure divisions sent revenues 118% higher, while the recent £25mln acquisition of CellRight gives it reason to be excited
FTSE 100 ended in positive territory, having been lower earlier,..
Investments and investor services
TUI already tipped off the market that it enjoyed a strong second quarter performance.
Archive
Some the main stories on the Proactive newswire today
A look at some of the main news-driven risers and fallers in London
Tissue Regenix is funding the acquisition with a placing at 10p to raise £40mln
London stocks were on the front foot this morning, but they quickly retreated this afternoon...
Archive
A glance at some of the stories on today's proactive newswire
Some of the main risers and fallers in London at 3.45pm...
Tissue also now has contracts with the two largest US hospital purchase organisations (GPOs)